Pnc Financial Services Group, Inc. Heron Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 117 shares of HRTX stock, worth $187. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117

Previous 117 -0.0%

Holding current value

$187

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.71 - $3.06 $2,565 - $4,590	-1,500 Reduced 92.76%	117 $0
Q4 2023 Feb 09, 2024	SELL	$0.54 - $1.82 $49 - $165	-91 Reduced 5.33%	1,617 $2,000
Q4 2022 Feb 10, 2023	SELL	$2.25 - $4.67 $900 - $1,868	-400 Reduced 18.98%	1,708 $4,000
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $673 - $1,842	-293 Reduced 12.2%	2,108 $5,000
Q1 2022 May 12, 2022	BUY	$4.63 - $9.94 $3,208 - $6,888	693 Added 40.57%	2,401 $13,000
Q3 2021 Nov 05, 2021	SELL	$10.13 - $15.0 $33,347 - $49,380	-3,292 Reduced 65.84%	1,708 $18,000
Q2 2021 Aug 06, 2021	BUY	$13.27 - $18.48 $15,778 - $21,972	1,189 Added 31.2%	5,000 $77,000
Q1 2021 May 07, 2021	BUY	$14.49 - $20.72 $1,318 - $1,885	91 Added 2.45%	3,811 $61,000
Q4 2020 Feb 12, 2021	SELL	$14.61 - $22.14 $10,066 - $15,254	-689 Reduced 15.63%	3,720 $78,000
Q3 2020 Nov 06, 2020	BUY	$13.67 - $17.77 $3,731 - $4,851	273 Added 6.6%	4,409 $65,000
Q2 2020 Aug 07, 2020	BUY	$10.89 - $21.47 $15,659 - $30,873	1,438 Added 53.3%	4,136 $60,000
Q1 2020 May 08, 2020	BUY	$10.23 - $24.56 $21,114 - $50,691	2,064 Added 325.55%	2,698 $31,000
Q4 2019 Feb 07, 2020	SELL	$17.42 - $26.61 $3,344 - $5,109	-192 Reduced 23.24%	634 $14,000
Q3 2019 Nov 08, 2019	BUY	$16.36 - $21.39 $3,010 - $3,935	184 Added 28.66%	826 $15,000
Q2 2019 Aug 09, 2019	SELL	$16.93 - $26.22 $1.24 Million - $1.92 Million	-73,106 Reduced 99.13%	642 $0
Q1 2019 May 10, 2019	BUY	$23.15 - $28.34 $621,971 - $761,410	26,867 Added 57.31%	73,748 $0
Q4 2018 Feb 08, 2019	SELL	$22.03 - $32.01 $51,351 - $74,615	-2,331 Reduced 4.74%	46,881 $1.22 Million
Q3 2018 Nov 09, 2018	BUY	$30.0 - $40.85 $12,570 - $17,116	419 Added 0.86%	49,212 $0
Q2 2018 Aug 10, 2018	BUY	$26.4 - $42.0 $1.29 Million - $2.05 Million	48,793 New	48,793 $0
Q4 2017 Feb 09, 2018	SELL	$14.8 - $18.85 $22,200 - $28,275	-1,500 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$14.65 - $16.85 $21,975 - $25,275	1,500	1,500 $0

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $190M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Heron Therapeutics, Inc. Transaction History